Growth Metrics

Sarepta Therapeutics (SRPT) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 19.97%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 38.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.22%
Dec 31, 2025 -41.94%
Sep 30, 2025 11.29%
Jun 30, 2025 41.79%
Mar 31, 2025 -62.12%
Dec 31, 2024 42.56%
Sep 30, 2024 39.21%
Jun 30, 2024 27.64%
Mar 31, 2024 30.38%
Dec 31, 2023 52.75%
Sep 30, 2023 40.72%
Jun 30, 2023 45.86%
Mar 31, 2023 -209.14%
Dec 31, 2022 50.33%
Sep 30, 2022 -26.83%
Jun 30, 2022 5.74%
Mar 31, 2022 -11.07%
Dec 31, 2021 19.19%
Sep 30, 2021 14.26%
Jun 30, 2021 9.35%
Mar 31, 2021 -67.86%
Dec 31, 2020 -99.07%
Sep 30, 2020 -60.27%
Jun 30, 2020 -33.74%
Mar 31, 2020 -30.22%
Dec 31, 2019 -38.64%
Sep 30, 2019 -30.58%
Jun 30, 2019 -64.32%
Mar 31, 2019 -8.64%
Dec 31, 2018 -29.78%
Sep 30, 2018 -13.85%
Jun 30, 2018 -37.42%
Mar 31, 2018 17.01%
Dec 31, 2017 18.74%
Sep 30, 2017 -12.33%
Jun 30, 2017 -27.71%
Mar 31, 2017 74.87%
Dec 31, 2016 -39.12%
Sep 30, 2016 -31.65%
Jun 30, 2016 -53.86%
Mar 31, 2016 -57.91%
Dec 31, 2015 -84.38%
Sep 30, 2015 -96.35%
Jun 30, 2015 -97.69%
Mar 31, 2015 -108.98%
Dec 31, 2014 -71.58%
Sep 30, 2014 -44.89%
Jun 30, 2014 -44.78%
Mar 31, 2014 -66.51%
Dec 31, 2013 -170.97%
Sep 30, 2013 -88.47%
Jun 30, 2013 -30.96%